Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.


GREY:ALEAF - Post by User

Bullboard Posts
Comment by MrOptimizationon Apr 30, 2019 12:06pm
80 Views
Post# 29689124

RE:RE:RE:What to do! What to do!

RE:RE:RE:What to do! What to do!

Yeah I think so too. I dont think it would of been to any benefit to discuss any license deals or where they are in terms of licensing progressions, when the focus from investors would still be their net loss. The earnings growth is irrelevant because they had like no revenues the year prior. And I'm surprised at the percentage of revenues that came from consultations services and research.

What I see as the floor is 1.40-1.45, and no one can ever time it perfectly. I'm gonna wait 1-2 days, and hope i'm not too late to get into this one! In 6 months time, I expect to see some good news releases on license deals, revenue sales via shoppers drug mart, production increasing, etc.

 

Bullboard Posts